Radboud University Medical Centre, Nijmegen
Nederland
Presentatie(s) van deze spreker
donderdag 24 april 2014 om 17:48 - 18:00
Liraglutide reverses insulin-associated weight gain, improves glycemic control and decreases insulin dose in patients with type 2 diabetes. Results from a 26-week, randomized, controlled trial (ELEGANT)